PCORI hosted a multi-stakeholder workshop in Washington, D.C., to discuss whether comparative clinical effectiveness research (CER) can help to answer questions surrounding treatment of Multiple Sclerosis.
In-person attendance was by invitation only but the public was welcome to listen in via teleconference and webinar. We invited representatives of a wide range of stakeholder groups, including patients, caregivers, clinicians, industry, payers, and researchers to participate in the discussion.
- Participants List
- Topic Brief
- Submitted Breakout Group Topics and Questions
- Presentation Slides
- Meeting Summary
Teleconference Audio Recordings
- General Session
- Breakout Session 1: Comparison of DMTs, including differential effects in subgroups
- Breakout Session 2: Care strategies
- Breakout Session 3: Non-pharmacologic therapy for specific symptoms and overall health
- Breakout Session 4: Timing of therapy and study design